维普期刊资源整合服务平台（V6.5）

292篇 您的检索式：期刊名="Mabs"

选中清除导出查看参考文献查看引证文献引用追踪共15页首页上一页第1页下一页末页 /15 跳转

	题名	作者	年代	出处	被引量
1	The VEGF family in cancer and antibody-based strategies for their inhibition显示文摘	Laura A. Sullivan Rolf A. Brekken	2010	mAbs2010，，：	2
2	A novel tetravalent bispe-cific YandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30 tumor cells显示文摘	Reusch U Burkhardt C Fucek I	2014	MAbs2014，6，3：	1
3	Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies 显示文摘	Du Y Walsh A Ehrick R	2012	MAbs2012，4，5：	1
4	World Bispecific Antibody Summit,September 27-28,2011,Boston, MA 显示文摘	Dhimolea ? Reichert JM	2012	MAbs2012，4，1：	1
5	Nimotu- zumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin显示文摘	Ramakrishnan MS Eswaraiah A Crombet T	2009	MAbs2009，1，1：	1
6	Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry显示文摘	ZHU L GUO Q GUO H	2014	MAbs2014，6，6：	1
7	Fusion protein technologies for biophar- maceuticais: Applications and challenges 显示文摘	Berger S Lowe P Tesar M	2015	Mabs2015，7，3：	1
8	Brentuximab vedotin显示文摘	van de Donk NW Dhimolea E	2012	MAbs2012，4，4：	1
9	Antibodies to watch in 2015显示文摘	REICHERT JM	2015	MAbs2015，7，1：	1
10	A chemical and computational approach to comprehensive glycation characte- rization on antibodies 显示文摘	Saleem RA Affholter BR Deng S	2015	MAbs2015，7，4：	1
11	Antibodies to watch in 2010 显示文摘	Reichert JM	2010	MAbs2010，2，1：	1
12	Global antibody development trends 显示文摘	Reichert JM	2009	MAbs2009，1，1：	1
13	Neonatal Fc receptor and IgG- based therapeutics 显示文摘	Kuo T T Aveson V G	2011	MAbs2011，3，5：	1
14	Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin显示文摘	Ramakrishnan M S Eswaraiah A Crombet T	2009	MAbs2009，1，1：	1
15	Biochemical and phar- macological characterization of human c-Met neutralizing monoclonal antibody CE-355621显示文摘	Michaud NR Jani JP Hillerman S	2012	MAbs2012，4，6：	1
16	Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies 显示文摘	Beck A Reichert J M	2011	MAbs2011，3，5：	1
17	Comparability analysis of anti-CD20 commercial(rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches 显示文摘	Li C Rossomando A Wu SL	2013	MAbs2013，5，4：	1
18	Motavizumab显示文摘	Cingoz O	2009	MAbs2009，1，5：	1
19	Certolizumab pegol 显示文摘	Goel N Stephens S	2010	MAbs2010，2，2：	1
20	Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glyco- sylation profiles-Part 2 : Mass spectrometric methods 显示文摘	REUSCH D HABERGER M FALCK D	2015	MAbs2015，7，4：	1

返回顶部每页显示：

共15页首页上一页第1页下一页末页 /15 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示